Insider Transactions in Q4 2024 at Neumora Therapeutics, Inc. (NMRA)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 18
2024
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
14,049
-41.14%
|
$238,833
$17.03 P/Share
|
|
Oct 18
2024
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
14,049
+18.88%
|
$70,245
$5.66 P/Share
|
|
Oct 17
2024
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
7,739
-27.8%
|
$131,563
$17.01 P/Share
|
|
Oct 17
2024
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
7,739
+9.14%
|
$46,434
$6.54 P/Share
|
|
Oct 10
2024
|
Robert A. Lenz Head of R&D |
SELL
Open market or private sale
|
Direct |
8,260
-2.56%
|
$123,900
$15.09 P/Share
|
|
Oct 09
2024
|
Robert A. Lenz Head of R&D |
SELL
Open market or private sale
|
Direct |
5,563
-1.69%
|
$83,445
$15.01 P/Share
|